More importantly, prospective studies and a meta-analysis carried out in this particular “inflammatory subtype” of SSc patients have linked the presence of elevated CRP levels (cutoff >5 mg/L) to worse health outcomes such as an increased risk of pulmonary hypertension (7), progressive fibrosis, and higher mortality (8, 9). Here, CRP is linked to systemic sclerosis.